Hodges Capital Management Inc. Boston Scientific Corp Transaction History

Hodges Capital Management Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 07, 2021	SELL	$35.27 - $39.67 $320,957 - $360,997	-9,100 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$33.15 - $41.97 $307,897 - $389,817	-9,288 Reduced 50.51%	9,100 $327,000
Q2 2020 Jul 22, 2020	SELL	$30.19 - $39.11 $188,687 - $244,437	-6,250 Reduced 25.37%	18,388 $646,000
Q1 2020 May 04, 2020	SELL	$25.83 - $45.71 $573,426 - $1.01 Million	-22,200 Reduced 47.4%	24,638 $804,000
Q4 2019 Feb 04, 2020	SELL	$37.87 - $45.37 $439,140 - $526,110	-11,596 Reduced 19.84%	46,838 $2.12 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $249,922 - $269,390	-6,200 Reduced 9.59%	58,434 $2.38 Million
Q2 2019 Aug 22, 2019	SELL	$34.91 - $42.98 $5.78 Million - $7.11 Million	-165,455 Reduced 71.91%	64,634 $2.78 Million
Q1 2019 Apr 15, 2019	SELL	$32.91 - $40.75 $2.13 Million - $2.64 Million	-64,810 Reduced 21.98%	230,089 $8.83 Million
Q4 2018 Feb 08, 2019	BUY	$31.73 - $39.04 $4.05 Million - $4.98 Million	127,599 Added 76.27%	294,899 $10.4 Million
Q3 2018 Oct 29, 2018	BUY	$32.83 - $38.63 $5.49 Million - $6.46 Million	167,300 New	167,300 $6.44 Million

1,607

1.19B

6.83M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $152B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.